Treatment-free holidays may be possible for people with atopic dermatitis (AD) who use tapinarof cream, 1% (Vtama, Organon), according to new results from ADORING 3 presented at the 2025 American Academy of Dermatology’s annual meeting in Orlando, FL. Linda Stein Gold, MD, Director of Clinical Research in the Department of Dermatology at Henry Ford Health in Detroit, MI, shares the topline results of the study and discusses this non-steroidal agent’s role in treating AD.
